Anthem (ANTM) Says Policy on Sarepta's (SRPT) DMD Drug Exondys 51 Unchanged - Bloomberg
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aetna (AET) covers Sarepta Therapeutics (SRPT) Exondys 51, with restrictions - Bloomberg
- PICO Holdings (PICO) Announces Leadership, Governance Changes; Terminates Central Square Agreement
- Streetinsider.com's Hot Lunchtime Reads 12/2: (FNMA) (SRPT) (GALE) (NVCN)
Create E-mail Alert Related CategoriesManagement Comments, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!